MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 18.04.2026
Grifols, S.A. ROE 2011-2026 | GRFS
ROE Jährlich Grifols, S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 9.2 | 14.4 | 18.25 | 20.09 | 23.63 | 25.72 | 26.75 | 30.99 | 27.68 | 6.6 |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 30.99 | 6.6 | 20.33 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K |  USA |
 |
Exelixis
EXEL
|
36.21 | $ 48.7 | 9.64 % | $ 13.2 B | USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M |  China |
 |
Fortress Biotech
FBIO
|
13.66 | $ 2.55 | 3.66 % | $ 71.1 M | USA |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Galapagos NV
GLPG
|
-11.44 | $ 28.81 | 1.48 % | $ 2.69 B |  Belgium |
 |
Genmab A/S
GMAB
|
24.88 | $ 27.89 | 1.28 % | $ 17.2 B |  Danmark |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | France |
 |
Genprex
GNPX
|
-203.83 | $ 0.89 | 0.58 % | $ 830 K | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-380.03 | - | - | $ 269 M | USA |
 |
InflaRx N.V.
IFRX
|
-43.64 | $ 2.5 | 26.9 % | $ 152 M | Germany |
 |
Ionis Pharmaceuticals
IONS
|
-46.9 | $ 76.85 | 2.13 % | $ 12.3 B | USA |
 |
Kamada Ltd.
KMDA
|
9.59 | $ 8.28 | 0.85 % | $ 260 M |  Israel |
 |
Kymera Therapeutics
KYMR
|
-19.71 | $ 86.26 | 4.29 % | $ 7.29 B | USA |
 |
BioNTech SE
BNTX
|
1.11 | $ 95.26 | -0.25 % | $ 27.2 B | Germany |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
-0.49 | $ 232.55 | 0.11 % | $ 4.25 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | USA |
 |
Liquidia Corporation
LQDA
|
-154.03 | $ 42.14 | 5.01 % | $ 3.63 B | USA |
 |
INmune Bio
INMB
|
-195.26 | $ 1.52 | -1.3 % | $ 37.6 M | USA |
 |
Mirum Pharmaceuticals
MIRM
|
-7.42 | $ 110.08 | 4.04 % | $ 5.53 B | USA |
 |
MannKind Corporation
MNKD
|
-11.49 | $ 3.56 | 24.48 % | $ 1.09 B | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
30.9 | $ 21.48 | -3.89 % | $ 3.56 B | USA |
 |
Nanobiotix S.A.
NBTX
|
-47.67 | $ 41.86 | 20.39 % | $ 286 B | France |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
7.51 | $ 3.15 | 1.19 % | $ 655 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 3.35 | -4.29 % | $ 5.51 M | Israel |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | USA |
 |
Puma Biotechnology
PBYI
|
23.87 | $ 7.45 | 1.36 % | $ 373 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 24.17 | 3.2 % | $ 3.08 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Pfizer
PFE
|
8.99 | $ 26.53 | 0.3 % | $ 151 B | USA |